ELISA assay of dilutions of the starting ascites fluid ( -) the non-absorbed protein fraction (-----) and the purified antibody (-----) from a pool of fractions 8-10 shown in ( a ) . ( c ) SDS gel (10%, w/v) containing reducing agent. Tracks 1 and 5, molecular mass marker proteins (97 400,66 200,42 700,31 000,21 500 and 14 500 Da); track 2,5 pg of affinity purified monoclonal antibody 20N/2c; track 3,5 pug 20N/3g; track 4,5 pg 20N/4t. BIOCHEMICAL SOCIETY TRANSACTIONS ment, and by the presence of specific cell surface receptors which bind these factors. Growth factors may be organized into families by their structural similarity and by their ability to recognize same [epidermal growth factor (EGF), transforming growth factor (TGF-a)] or similar receptors [insulin, insulin-like growth factor (IGF I)]. Likewise, growth factor receptors may be organized into families. One such family is exemplified by the epidermal growth factor receptor (EGFR/c-erbB-1 ) and the c-erbB-2 protein (also known as HER2/neu). These molecules are similar in sequence and possess protein tyrosine kinase activity and the ability to autophosphorylate. The EGFR is responsible for generating a mitogenic response in cells after binding EGF or TGF-a. Presently, no ligand has been identified that binds to the c-erbB-2 protein. The over-expression of either molecule in NIH 3T3 cells leads to cell transformation (Velu et al., 1987; Di Fiore et al., 1987) . Frequently, over-expression of EGFR or c-erbB-2, sometimes as a consequence of gene amplification, has been reported in human tumours of epithelial origin. This over-expression has been reported to prognosticate short disease-free interval and survival of cancer patients (Sainsbury et al., 1987; Slamon et al., 1987) .
Recently, we have reported the production of polyclonal antibodies to two different short synthetic peptides derived from the sequence of the human c-erbB-2 protein. Both reagents were shown to recognize specifically the c-erbB-2 protein by immunoprecipitation, Western blotting and immunohistological staining in frozen and paraffin-embedded tissue sections (Gullick et al., 1987; Venter et al., 1087) . We report here the production of monoclonal antibodies to one of these sequences. Rats were immunized with a conjugate of synthetic peptide 2 0 N (residues 12 15-1225 of the open reading frame of the c-erbB-2 protein), coupled to keyhole limpet haemocyanin using glutaraldehyde. Cells obtained from mesenteric lymph nodes of one of the immunized animals, which expressed a high serum titre against the peptide determined by solid-phase radioimmunoassay (RIA), were fused with Y3 rat myeloma cells. Hybridomas secreting antibodies that reacted with the 2 0 N peptide were selected using the solid-phase RIA. Cell lines were obtained by limited dilution cloning. Three independent clones called 20N/2c, 20N/3g and 20N/4t were obtained and the hybridomas were grown as ascites in syngeneic rats. Before determining the properties of the antibodies they were purified to homogeneity using affinity chromatography. An affinity resin was prepared by coupling 1 mg of free peptide 20N/ml of matrix (TSK HW-65F, Pierce). Ascites fluid was mixed with the affinity resin and incubated for 2 h at room temperature. Unbound proteins were removed by washing with 100 mMsodium phosphate buffer pH 8.0, and the antibodies eluted with 50 mM-glycine buffer, pH 2.2 (Fig. 1 a) . The presence of specific antibodies in the starting material, unbound fraction and pooled eluate was determined by enzyme-linked immunosorbent assay (ELISA), using plates coated with the peptide (Gullick et al., 1986) . The antibody was efficiently retained and eluted from the affinity column (Fig. 1 b) . To determine the purity of the eluted fraction 5 pg aliquots derived from purifications of each antibody were analysed on reducing SDS gels. The antibodies were substantially pure since they contained only proteins of 50 000 Da molecular mass (presumably immunoglobulin heavy chain) and 25 000 Da (light chain) (Fig. lc, tracks 3 and 4) . In the case of antibody 20N/2c, an additional band was visible with a molecular mass of 75 000 Da, possibly a dimer of one light and one heavy chain (Fig. 1 c, track 2 ).
The purified antibodies were then assessed for their ability to recognize the native c-erbB-2 protein. NIH 3T3 cells expressing high levels of rat neu protein, the rat homologue of the human c-erbB-2 protein (DHFR-G8 cells, Hung et af., 1086), were labelled with [35S]methionine and cell lysates were immunoprecipitated using either polyclonal antibodies to the 2 0 N peptide or the monoclonal antibodies. A protein of 185 000 Da molecular mass was recognized by the polyclonal antibodies (Fig. 2, track 1) which was not seen when the reaction was carried out in the presence of an excess of free peptide (Fig. 2, track 2) . The monoclonal antibody 20N/2c also recognized a similar sized protein (Fig. 2, track  3 ), but much more weakly than when using an equivalent amount of the polyclonal antibody (Fig. 2, track 1) . The reaction was, however, also competed by an excess of free peptide (Fig. 2, track 4) . No material was immunoprecipitated specifically by either the 20N/3g (Fig. 2, tracks 5 and 6 ) o r the 20N/4t antibodies (not shown).
The observed behaviour might be due either to the antibodies possessing low affinity for the c-erbB-2 protein o r to their inability to react with protein A which was used t o absorb the immune complexes. To test this, the antibodies were coupled directly to Affigel 10 (Bio-Rad). The directly coupled antibodies failed to recognize specifically the c-erbB-2 protein in labelled cell lysates. The reason for this
----- The immunoprecipitated proteins were resolved on a 7% (w/v) SDS gel containing reducing agent followed by autoradiography. Tracks 1 and 2, immunoprecipitation using 5 pg of affinity purified polyclonal antibodies raised in rabbits to the 2 0 N peptide; tracks 3 and 4, 5 pg of affinity purified 20N/2c monoclonal antibody; tracks 5 and 6, 5 pg of affinity purified 20N/3g monoclonal antibody. Tracks 2 , 4 and 6 show the products of the immunoprecipitation reaction carried out in the presence of an excess of free synthetic peptide 20N. behaviour is not known, but may be a consequence of inactivation of the antibodies by the coupling procedure. We next tested the antibodies for their ability to immunohistologically stain thin sections of frozen and paraffin-embedded human tissues and tumours known to express low or high amounts of the c-erbB-2 protein. The antibodies gave specific staining reactions only on those tissues or tumours previously demonstrated to express high levels of the c-erbB-2 protein. However, the reactions were quite variable and inconsistent in comparison to the polyclonal antibodies raised to the same sequence and to another sequence ( 2 IN, residues 1243-1255) which always gave coherent staining patterns (Venter et ul., 1987) , Also the monoclonal antibodies had to be used at high concentrations ( > 50 ,ug/ml) to see specific staining and this resulted in variable background staining.
In conclusion, three hybridomas were selected using a solid-phase RIA which recognized specifically the 2 0 N peptide immunogen. Purified antibodies were prepared with high yield from ascites fluid using affinity chromatography on immobilized peptide. One antibody immunoprecipitated the native c-erbB-2 protein, but the reaction was weak when compared with polyclonal antibodies raised in rabbits to the same sequence. None of the antibodies proved capable of reliable immunohistological staining of thin sections of human tissue, probably due to their low affinity. To raise monoclonal antipeptide antibodies of high affinity, which are clearly present in a polyclonal immune response, it may be necessary to screen large numbers of clones using antipeptide response as the criterion of positive reaction, or alternatively it may be preferable to screen using reaction with the native immunogen by immunoprecipitation or immunohistological analysis. The 20N/2c antibody is, however, the first monoclonal antibody described which recognizes the native human c-erbB-2 protein, and, despite its apparent low affinity, it may prove useful in attempts to purify the c-erbB-2 protein from cell and tissue lysates (Ohlson et ui., 1988 lymphoid tissues (SALT) which mediates cutaneous immunosurveillance against infecting organisms, noxious chemicals, and tumour neoantigens (Streilein, 1983) .
One of the most exciting new developments over the past 5 years in the field of immunodermatology has been the discovery that, far from being passive bystanders in the pathophysiology of cutaneous inflammation, keratinocytes actively participate by secreting a whole range of low molecular mass substances with immunoregulatory properties (Luger et al., 1 9 8 5~) .
The current state of our knowledge of these immunoregulatory cytokines, as well as the evidence for their proposed role in the pathogenesis of cutaneous disorders as diverse as eczema, psoriasis, cutaneous T-cell lymphoma and scleroderma, is reviewed.
Characterization arid biological properties of epidermal cytokiries
Epidermal-cell-derived thymocyte activating factor (ETAF) is a 15-25 kDa protein with biological properties very similar t o interleukin 1 (IL-l), which is secreted by murine and human kcratinocytes, the human epidermoid squamous carcinoma cell lines SCC, A 43 1 and COLO 16, and the murine transformed keratinocyte cell line Pam 2 12 (Luger et ai., 1981; Saudcr et ui., 1982; Luger et ai., 1982). Normal human stratum corneum contains a large amount of ETAF/IL 1 (Gahring et a[., 1985) . ETAF, like IL-1, augments mitogen-induced thymocyte proliferation and enhances the production of interleukin 2 (IL-2) by T lymphocytes. ETAF has three isoelectric points (PI) of 6.8, 5.4 and 4.8 (Luger et al., 1983; Sauder et al., 1984) . The exact relationship between ETAF and IL-1 is controversial. Kupper
